|
|
|
New family of 10 cancer related genes discovered
Introgen Therapeutics, Inc. (NASDAQ: INGN) has licensed a group of newly discovered and sequenced genes that appear to play a critical role in suppressing and preventing the development of lung and other cancers. This family of genes includes at least 10 members. Discovery of these tumor suppressor genes represents a joint collaborative effort by The University of Texas Southwestern Medical Center, The University of Texas M. D. Anderson Cancer Center, and the National Cancer Institute.Contact:
C. Channing Burke
c.burke@introgen.com
512-708-9310
Porter Novelli
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|